The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
As a disease with the highest disease-associated burden worldwide, cancer has been the main subject of a considerable proportion of medical research in recent years, intending to find more effective therapeutic approaches with fewer side effects. Combining conventional methods with newer biologicall...
Main Authors: | Hamidreza Hassanian, Zahra Asadzadeh, Amir Baghbanzadeh, Afshin Derakhshani, Antoine Dufour, Nazanin Rostami Khosroshahi, Souzan Najafi, Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.938063/full |
Similar Items
-
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?
by: Oronzo Brunetti, et al.
Published: (2020-04-01) -
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
by: Negar Hosseinkhani, et al.
Published: (2020-11-01) -
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
by: Omid Kooshkaki, et al.
Published: (2020-06-01) -
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
by: Zahra Asadzadeh, et al.
Published: (2020-04-01) -
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study
by: Mahdi Abdoli Shadbad, et al.
Published: (2022-10-01)